tiprankstipranks
Memphasys Ltd (AU:MEM)
ASX:MEM

Memphasys Ltd (MEM) Share Price & Analysis

3 Followers

MEM Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week Range<AU$0.01 - AU$0.02
Previous CloseAU$0.01
Volume694.30K
Average Volume (3M)1.11M
Market Cap
AU$11.06M
Enterprise ValueAU$16.36M
Total Cash (Recent Filing)AU$269.08K
Total Debt (Recent Filing)AU$5.56M
Price to Earnings (P/E)
Beta-0.09
Aug 28, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,367,742,273
10 Day Avg. Volume832,928
30 Day Avg. Volume1,114,752
Standard Deviation0.49
R-Squared0.00028
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

21.87%0.00%0.00%78.13%
21.87%
Insiders
0.00% Other Institutional Investors
78.13% Public Companies and
Individual Investors

MEM FAQ

What was Memphasys Ltd’s price range in the past 12 months?
Memphasys Ltd lowest share price was <AU$0.01 and its highest was AU$0.02 in the past 12 months.
    What is Memphasys Ltd’s market cap?
    Currently, no data Available
    When is Memphasys Ltd’s upcoming earnings report date?
    Memphasys Ltd’s upcoming earnings report date is Aug 28, 2024 which is in 55 days.
      How were Memphasys Ltd’s earnings last quarter?
      Memphasys Ltd released its earnings results on Feb 26, 2024. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
        Is Memphasys Ltd overvalued?
        According to Wall Street analysts Memphasys Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Memphasys Ltd pay dividends?
          Memphasys Ltd does not currently pay dividends.
          What is Memphasys Ltd’s EPS estimate?
          Memphasys Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Memphasys Ltd have?
          Memphasys Ltd has 1,382,748,200 shares outstanding.
            What happened to Memphasys Ltd’s price movement after its last earnings report?
            Memphasys Ltd reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Memphasys Ltd?
              Currently, no hedge funds are holding shares in AU:MEM
              ---

              Memphasys Ltd Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Fundamentals

              Return on Equity
              -55.98%
              Trailing 12-Months
              Asset Growth
              -15.86%
              Trailing 12-Months

              Company Description

              Memphasys Ltd

              Memphasys Ltd operates as a bio-separations company in Australia. It is engaged in developing and commercializing separation techniques based on the company's proprietary membrane technology. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Genetic Signatures Ltd.
              Anatara Lifesciences Ltd
              Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis